miR-185 Inhibits Hepatocellular Carcinoma Growth by Targeting the DNMT1/PTEN/Akt Pathway
2014 · American Journal Of Pathology · 100 citations
https://doi.org/10.1016/j.ajpath.2014.05.004
C
Chang Han
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
8.6K
Citations
25
h-index
32
i10-index
Chang Han is an academic researcher from Ningbo University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer-related molecular mechanisms research & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 25, co-authored 81 publications.
ORCID: 0000-0003-2285-1247Papers by this author
worksmiR-101 Inhibits Cholangiocarcinoma Angiogenesis through Targeting Vascular Endothelial Growth Factor (VEGF)
2013 · American Journal Of Pathology · 61 citations
https://doi.org/10.1016/j.ajpath.2013.01.045
Bioinformatic Methods and Bridging of Assay Results for Reliable Tumor Mutational Burden Assessment in Non-Small-Cell Lung Cancer
2019 · Molecular Diagnosis & Therapy · 55 citations
https://doi.org/10.1007/s40291-019-00408-y
Deletion of Mir155 Prevents Fas-Induced Liver Injury through Up-Regulation of Mcl-1
2015 · American Journal Of Pathology · 22 citations
https://doi.org/10.1016/j.ajpath.2014.12.020
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat